DE602004029580D1 - Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen - Google Patents
Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungenInfo
- Publication number
- DE602004029580D1 DE602004029580D1 DE602004029580T DE602004029580T DE602004029580D1 DE 602004029580 D1 DE602004029580 D1 DE 602004029580D1 DE 602004029580 T DE602004029580 T DE 602004029580T DE 602004029580 T DE602004029580 T DE 602004029580T DE 602004029580 D1 DE602004029580 D1 DE 602004029580D1
- Authority
- DE
- Germany
- Prior art keywords
- indoind
- derivatives
- substituted
- treatment
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0302232A SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Novel Compounds |
PCT/GB2004/003502 WO2005019171A1 (en) | 2003-08-18 | 2004-08-16 | Substituted indole derivatives for pharmaceutical composition for treating respiratory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004029580D1 true DE602004029580D1 (de) | 2010-11-25 |
Family
ID=28450248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004029580T Active DE602004029580D1 (de) | 2003-08-18 | 2004-08-16 | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen |
Country Status (18)
Country | Link |
---|---|
US (1) | US7709521B2 (de) |
EP (1) | EP1656347B1 (de) |
JP (1) | JP4709758B2 (de) |
AR (1) | AR045462A1 (de) |
AT (1) | ATE484494T1 (de) |
CY (1) | CY1110977T1 (de) |
DE (1) | DE602004029580D1 (de) |
DK (1) | DK1656347T3 (de) |
ES (1) | ES2352201T3 (de) |
MY (1) | MY143367A (de) |
PL (1) | PL1656347T3 (de) |
PT (1) | PT1656347E (de) |
SA (1) | SA04250255B1 (de) |
SE (1) | SE0302232D0 (de) |
SI (1) | SI1656347T1 (de) |
TW (1) | TW200510303A (de) |
UY (1) | UY28473A1 (de) |
WO (1) | WO2005019171A1 (de) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0202241D0 (sv) * | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
SE0303180D0 (sv) * | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
PL1725553T3 (pl) | 2004-03-11 | 2008-10-31 | Idorsia Pharmaceuticals Ltd | Pochodne tetrahydropirydoindolu |
EP1833791B1 (de) | 2004-12-27 | 2011-08-03 | Actelion Pharmaceuticals Ltd. | 2,3,4,9-tetrahydro-1h-carbazol-derivative als crth2-rezeptorantagonisten |
GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
GB0505048D0 (en) * | 2005-03-11 | 2005-04-20 | Oxagen Ltd | Compounds with PGD antagonist activity |
EP1916245B1 (de) | 2005-07-22 | 2011-10-26 | Shionogi & Co., Ltd. | Indolderivat mit pgd2-rezeptor-antagonistischer wirkung |
WO2007010965A1 (ja) | 2005-07-22 | 2007-01-25 | Shionogi & Co., Ltd. | Pgd2受容体アンタゴニスト活性を有するアザインドール酸誘導体 |
GB0521275D0 (en) * | 2005-10-19 | 2005-11-30 | Argenta Discovery Ltd | 3-Aminoindole compounds |
CN101454284A (zh) * | 2006-05-26 | 2009-06-10 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
US20150072963A1 (en) * | 2006-06-16 | 2015-03-12 | The Trustees Of The University Of Pennsylvania | Compositions and methods for regulating hair growth |
PL2037967T3 (pl) * | 2006-06-16 | 2017-07-31 | The Trustees Of The University Of Pennsylvania | Antagoniści receptora prostaglandyny D2 w leczeniu łysienia androgenowego |
PL2046740T3 (pl) | 2006-07-22 | 2012-10-31 | Oxagen Ltd | Związki o aktywności antagonisty CRTH2 |
NZ574705A (en) | 2006-08-07 | 2011-12-22 | Actelion Pharmaceuticals Ltd | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives |
CN101679251B (zh) | 2007-04-11 | 2013-10-02 | 橘生药品工业株式会社 | (氮杂)吲哚衍生物及其医药用途 |
US7960567B2 (en) * | 2007-05-02 | 2011-06-14 | Amgen Inc. | Compounds and methods useful for treating asthma and allergic inflammation |
EP2327693B9 (de) | 2007-12-14 | 2012-10-24 | Pulmagen Therapeutics (Asthma) Limited | Indole und ihre therapeutische Verwendung |
US7750027B2 (en) | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
AU2009204700B2 (en) | 2008-01-18 | 2013-07-04 | Atopix Therapeutics Limited | Compounds having CRTH2 antagonist activity |
JP2011509991A (ja) | 2008-01-22 | 2011-03-31 | オキサジェン リミテッド | Crth2アンタゴニスト活性を有する化合物 |
EP2265581A1 (de) | 2008-01-22 | 2010-12-29 | Oxagen Limited | Verbindungen mit crth2-antagonistischer wirkung |
WO2009151910A2 (en) * | 2008-05-25 | 2009-12-17 | Wyeth | Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer |
KR20110098749A (ko) * | 2008-12-25 | 2011-09-01 | 다이쇼 세이야꾸 가부시끼가이샤 | 이소퀴놀린 유도체 |
EP2433124B1 (de) * | 2009-05-19 | 2017-03-01 | Vivia Biotech S.L. | Verfahren für personalisierte medizinische ex-vivo-tests für hämatologische neoplasmen |
KR101752932B1 (ko) * | 2009-07-06 | 2017-07-03 | 아스트라제네카 아베 | 4-(아세틸아미노))-3-[(4-클로로-페닐)티오]-2-메틸-1h-인돌-1-아세트산의 중간체 및 그의 제조 방법 |
CA2789427A1 (en) | 2010-02-11 | 2011-08-18 | Vanderbilt University | Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
KR101444572B1 (ko) | 2010-03-22 | 2014-09-24 | 액테리온 파마슈티칼 리미티드 | 3-(헤테로아릴-아미노)-1,2,3,4-테트라히드로-9h-카르바졸 유도체 및 이의 프로스타글란딘 d2 수용체 조절제로서의 용도 |
WO2011162274A1 (ja) | 2010-06-23 | 2011-12-29 | 大正製薬株式会社 | イソキノリン誘導体 |
EP2457900A1 (de) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten |
DK2697223T3 (en) | 2011-04-14 | 2016-09-05 | Actelion Pharmaceuticals Ltd | 7- (heteroaryl-amino) -6,7,8,9-tetrahydro-pyrido [1,2-a] indole-acetic acid derivatives and their use as prostaglandin D2 receptor |
EP2526945A1 (de) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Neue CRTH2-Antagonisten |
EP2548876A1 (de) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | Neue CRTH2-Antagonisten |
EP2548863A1 (de) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | Neue CRTH2-Antagonisten |
WO2013088109A1 (en) | 2011-12-16 | 2013-06-20 | Oxagen Limited | Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis |
CA2867901A1 (en) | 2012-03-21 | 2013-09-26 | The Trustees Of The University Of Pennsylvania | Compositions and methods for regulating hair growth |
MX368179B (es) | 2014-03-17 | 2019-09-23 | Idorsia Pharmaceuticals Ltd | Derivados del acido acetico azaindol y su uso como moduladores de receptor de prostaglandina d2. |
MX2016011900A (es) | 2014-03-18 | 2016-12-05 | Actelion Pharmaceuticals Ltd | Derivados de acido azaindol-acetico y su uso como moduladores del receptor de prostaglandina d2. |
GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
TWI695831B (zh) | 2014-09-13 | 2020-06-11 | 香港商南北兄弟藥業投資有限公司 | Crth2拮抗劑化合物及其用途 |
US20200078351A1 (en) | 2015-07-30 | 2020-03-12 | The Trustees Of The University Of Pennsylvania | Single nucleotide polymorphic alleles of human dp-2 gene for detection of susceptibility to hair growth inhibition by pgd2 |
PL3350179T3 (pl) | 2015-09-15 | 2021-08-02 | Idorsia Pharmaceuticals Ltd | Krystaliczne postacie |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE790679A (fr) * | 1971-11-03 | 1973-04-27 | Ici Ltd | Derives de l'indole |
JPH0615542B2 (ja) | 1986-07-22 | 1994-03-02 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
US5095031A (en) * | 1990-08-20 | 1992-03-10 | Abbott Laboratories | Indole derivatives which inhibit leukotriene biosynthesis |
WO1993005020A1 (en) | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
FR2692574B1 (fr) | 1992-06-23 | 1995-06-23 | Sanofi Elf | Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles. |
CA2156420A1 (en) | 1993-02-24 | 1994-09-01 | Theresa M. Williams | Inhibitors of hiv reverse transcriptase |
US5486525A (en) | 1993-12-16 | 1996-01-23 | Abbott Laboratories | Platelet activating factor antagonists: imidazopyridine indoles |
US5567711A (en) | 1995-04-19 | 1996-10-22 | Abbott Laboratories | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
TW472045B (en) | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
ZA987554B (en) | 1997-08-21 | 2000-02-21 | American Home Prod | Methods for the solid phase synthesis of substituted indole compounds. |
ATE239013T1 (de) | 1997-12-19 | 2003-05-15 | Lilly Co Eli | Hypoglykamische imidazoline derivate |
US6916841B2 (en) | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
AU5886500A (en) | 1999-06-23 | 2001-01-09 | Sepracor, Inc. | Indolyl-benzimidazole antibacterials, and methods of use thereof |
AU7962200A (en) | 1999-10-29 | 2001-05-14 | Wakunaga Pharmaceutical Co., Ltd | Novel indole derivatives and drugs containing the same as the active ingredient |
CA2699568C (en) | 1999-12-24 | 2013-03-12 | Aventis Pharma Limited | Azaindoles |
CA2406979A1 (en) * | 2000-05-31 | 2001-12-06 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
US6878522B2 (en) * | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
TWI317634B (en) | 2001-12-13 | 2009-12-01 | Nat Health Research Institutes | Aroyl indoles compounds |
RU2337909C2 (ru) | 2002-02-01 | 2008-11-10 | Ф.Хоффманн-Ля Рош Аг | Замещенные индолы и фармацевтическая композиция, обладающая агонистической активностью в отношении альфа-1a/l адренорецептора |
SE0200411D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
SE0200356D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
AU2003231509A1 (en) | 2002-05-16 | 2003-12-02 | Shionogi And Co., Ltd. | Compound exhibiting pgd 2 receptor antagonism |
SE0201635D0 (sv) * | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0202241D0 (sv) * | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
SE0202463D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Novel compounds |
SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
CA2542716A1 (en) | 2003-10-14 | 2005-05-06 | Oxagen Limited | Compounds having crth2 antagonist activity |
SE0303180D0 (sv) | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
GB2422831A (en) | 2005-02-04 | 2006-08-09 | Oxagen Ltd | Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor |
CN101454284A (zh) | 2006-05-26 | 2009-06-10 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
CA2654026A1 (en) | 2006-06-08 | 2007-12-13 | Neurokey A/S | Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
EP2040688B1 (de) | 2006-06-28 | 2014-04-02 | Sanofi | Neue cxcr2 inhibitoren |
-
2003
- 2003-08-18 SE SE0302232A patent/SE0302232D0/xx unknown
-
2004
- 2004-08-06 TW TW093123728A patent/TW200510303A/zh unknown
- 2004-08-16 EP EP04768065A patent/EP1656347B1/de not_active Not-in-force
- 2004-08-16 DK DK04768065.7T patent/DK1656347T3/da active
- 2004-08-16 PL PL04768065T patent/PL1656347T3/pl unknown
- 2004-08-16 AT AT04768065T patent/ATE484494T1/de active
- 2004-08-16 ES ES04768065T patent/ES2352201T3/es active Active
- 2004-08-16 SI SI200431554T patent/SI1656347T1/sl unknown
- 2004-08-16 SA SA04250255A patent/SA04250255B1/ar unknown
- 2004-08-16 PT PT04768065T patent/PT1656347E/pt unknown
- 2004-08-16 JP JP2006523677A patent/JP4709758B2/ja not_active Expired - Fee Related
- 2004-08-16 MY MYPI20043328A patent/MY143367A/en unknown
- 2004-08-16 US US10/568,889 patent/US7709521B2/en not_active Expired - Fee Related
- 2004-08-16 WO PCT/GB2004/003502 patent/WO2005019171A1/en active Search and Examination
- 2004-08-16 DE DE602004029580T patent/DE602004029580D1/de active Active
- 2004-08-17 UY UY28473A patent/UY28473A1/es unknown
- 2004-08-18 AR ARP040102959A patent/AR045462A1/es not_active Application Discontinuation
-
2010
- 2010-12-09 CY CY20101101133T patent/CY1110977T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
TW200510303A (en) | 2005-03-16 |
US20060264444A1 (en) | 2006-11-23 |
PL1656347T3 (pl) | 2011-02-28 |
US7709521B2 (en) | 2010-05-04 |
AR045462A1 (es) | 2005-10-26 |
SE0302232D0 (sv) | 2003-08-18 |
EP1656347B1 (de) | 2010-10-13 |
MY143367A (en) | 2011-04-29 |
CY1110977T1 (el) | 2015-06-11 |
ES2352201T3 (es) | 2011-02-16 |
SI1656347T1 (sl) | 2011-01-31 |
EP1656347A1 (de) | 2006-05-17 |
DK1656347T3 (da) | 2011-01-10 |
JP2007502804A (ja) | 2007-02-15 |
SA04250255B1 (ar) | 2009-02-25 |
JP4709758B2 (ja) | 2011-06-22 |
UY28473A1 (es) | 2005-03-31 |
PT1656347E (pt) | 2010-12-09 |
WO2005019171A1 (en) | 2005-03-03 |
ATE484494T1 (de) | 2010-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
ATE417606T1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
DE602005017503D1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
ATE517085T1 (de) | Zur behandlung von atemwegserkrankungen geeignete phenoxyessigsäurederivate | |
DE602005017636D1 (de) | Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
ATE551100T1 (de) | Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen | |
ATE482709T1 (de) | Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
ATE375977T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
NO20033594D0 (no) | Fenetanolamin-derivater for behandling av luftveissykdommer | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
HK1085720A1 (en) | Substituted phenylalkanoic acid derivatives and their use for respiratory disease treatment | |
ATE516037T1 (de) | Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen | |
ATE517877T1 (de) | Neue arzneimittel zur behandlung von atemwegserkrankungen | |
DE602004029465D1 (de) | Externes Präparat zur Behandlung von Fusspilz | |
DE602006005640D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
DE60218375D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen | |
DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen |